AzTrials
AzTrials

InsomniaIpsyInsomniNCT01256099

Internet-CBT for Insomnia

A study testing Therapist guided Internet-CBT for insomnia, Brief Internet-CBT for insomnia, without support and Therapist Guided Internet-CBT for depression in people with Insomnia and Depression, run by Karolinska Institutet at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study includes two sub-trials. In trial 1 patients suffering from insomnia but not meeting the criteria for depression are randomised to either therapist guided Internet-based CBT for insomnia or to a control group with a non-guided, brief self-help program that acts as a placebo control. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Insomnia, Depression
What is being tested?
Therapist guided Internet-CBT for insomnia, Brief Internet-CBT for insomnia, without support and Therapist Guided Internet-CBT for depression
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
191 participants
Where
1 siteSweden
Study dates
Jan 2010to Feb 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Clinical level of Insomnia (more than 10 on ISI)
  • Meets criteria for Insomnia according to DSM-IV-TR
  • Enough language skills
  • Only Trial 2: Meets criteria for Major Depressive Disorder according to DSM-IV-TR

Who cannot join

  • Sleep disorders requiring other treatment
  • High consumption of alcohol/drugs that affect sleep
  • Started to use or changed the dose of antidepressant drug during the last 2 months
  • Somatic or psychiatric conditions requiring acute care
  • Working night shifts
  • Only Trial 1: Meets criteria for Major Depressive Disorder according to DSM-IV-TR

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Karolinska Institutet

    Stockholm

Other trials in Sweden

About this study

Official title: Guided Internet-treatment for Insomnia. Treatment Effects, Health Economics and Interaction With Depression

This study includes two sub-trials.

In trial 1 patients suffering from insomnia but not meeting the criteria for depression are randomised to either therapist guided Internet-based CBT for insomnia or to a control group with a non-guided, brief self-help program that acts as a placebo control. The primary purpose is to evaluate reduction in Insomnia severity (compared to placebo) after treatment and at follow-ups at 6-month, 1 year and 3 years. Secondary purpose is to evaluate the costeffectiveness of the treatment and to evaluate if the insomnia treatment has a preventive effect on future depressive episodes. Recruitment is done through mass media and includes all regions of Sweden. Initial assessment based on questionnaires and telephone interviews.

Read more

Trial 2 includes patients suffering from both Insomnia and depression. Randomization is done between either CBT for insomnia or CBT for depression (both Internet-based) to evaluate each respective treatment's effect on both insomnia and depression. The patients need for further treatment after the initial one will be measured and used as a secondary outcome. Recruitment is done through mass media but only citizens in the Stockholm area are included since the initial assessment are based on both questionnaires and telephone interviews as well as a visit at a psychiatrist located at the Internet psychiatry clinic in Stockholm.

Both trials will include health economic data and analysis. For the longer follow-up periods (1 and 3 years), registers will be used to analyse consumption of sleep medication and antidepressants as well as general health care utilization.

Conditions
Insomnia, Depression
Being tested
Therapist guided Internet-CBT for insomnia, Brief Internet-CBT for insomnia, without support, Therapist Guided Internet-CBT for depression
Keywords
Self-help treatment, Internet treatment, CBT, Prevention, Comorbidity
Medical subject headings
Sleep Initiation and Maintenance Disorders, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Therapist guided Internet-CBT for insomniaBehavioural

    An 8 week long, structured self-help program with weekly reports to, and feedback from, a CBT therapist over the Internet. Includes traditional CBT-methods for insomnia

  • Brief Internet-CBT for insomnia, without supportBehavioural

    No support and less text, not including the CBT-methods that are presumed to be most effective to reduce Insomnia symptoms

  • Therapist Guided Internet-CBT for depressionBehavioural

    An 9 week long, structured self-help program with weekly reports to, and feedback from, a CBT therapist over the Internet. Includes traditional CBT-methods for depression. Information and methods regarding sleep difficulties removed

Study groups in NCT01256099
Study groupRoleWhat they receive
Guided Internet-CBT for insomniaExperimentalNot described
Receives: Behavioral: Therapist guided Internet-CBT for insomnia
Control treatmentPlacebo comparatorNot described
Receives: Behavioral: Brief Internet-CBT for insomnia, without support
Guided Internet-CBT for insomnia (9)Experimental(9 weeks instead of 8)
Receives: Behavioral: Therapist guided Internet-CBT for insomnia
Guided Internet-CBT for depressionActive comparatorNot described
Receives: Behavioral: Therapist Guided Internet-CBT for depression

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Insomnia Severity Index (ISI)

    7-item, self-rated questionnaire measuring insomnia severity. Bastien, C. H., Vallières, A., \& Morin, C. M. (2001). Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Medicine, 2, 297-307.

    Measured: Post-treatment (9 weeks)

  2. MADRS-S

    The use of two primary outcomes are motivated since the purpose is to look at effects on both insomnia and depression. In trial 1 the former is used to predict the latter, and in Trial 2 the patientents suffer from both conditions.

    The MADRS-S is a 9-item self-rated measure of depression severity and screens for suicidality.

    Mattila-Evenden, M., Svanborg, P., Gustavsson, P., \& Åsberg, M. (1996). Determinants of self-rating and expert rating concordance in psychiatric out-patients, using the affective subscales of CPRS. Acta Psychiatr Scand, 94, 386-396.

    Measured: Post-treatment (9 weeks)

  3. ISI

    Measured: 6-month follow-up

  4. ISI

    Measured: 1-year follow-up

  5. ISI

    Measured: 3-years follow-up

  6. MADRS-S

    Measured: 6-month follow-up

  7. MADRS-S

    Measured: 1-year follow-up

  8. MADRS-S

    Measured: 3-years follow-up

Secondary outcomes (3)
  1. Sleep Diary

    One week of self-ratings on a number of sleep parameters, resluting in measures of sleep latency, total sleep time, sleep efficacy, number of nighttime awakenings, subjecitve sleep quality and daytime functioning

    Measured: Same as primary outcomes

  2. Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry (TIC-P)

    Health economic questionnaire evalutation cost for health care, abscence of work capacity and related costs.

    Hakkaart-Van Roijen, L.,Van Straten, A., \& Donker, M. (2002). Manual: Trimbos/iMTA Questionnaire for Costs Associated with Psychiatric Illness. Rotterdam: Erasmus University

    Measured: Same as Primary outcomes

  3. EQ-5D

    General quality of life measure to complement the TIC-P in health economic analysis.

    Hinz, A., Klaiberg, A., Brahler, E., \& Konig, H.H. (2006). The Quality of Life Questionnaire EQ-5D: modelling and norm values for the general population. Psychother.Psychosom.Med.Psychol., 56, 42-48.

    Measured: Same as primary outcomes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Dec 2010 (estimated)
  2. Study startJan 2010
  3. Primary completionFeb 2014
  4. Study completionFeb 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
191 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01256099
Sponsor's protocol ID
2009/1810-31/3
Acronym
IpsyInsomni
Status last verified
Apr 2015
First submitted
12 Oct 2010
Last updated
3 Apr 2015
Results posted
No
Data monitoring committee
No

Publications

  • Kraepelien M, Blom K, Forsell E, Hentati Isacsson N, Bjurner P, Morin CM, Jernelov S, Kaldo V. A very brief self-report scale for measuring insomnia severity using two items from the Insomnia Severity Index - development and validation in a clinical population. Sleep Med. 2021 May;81:365-374. doi: 10.1016/j.sleep.2021.03.003. Epub 2021 Mar 16.

    PubMed 33813233
  • Blom K, Jernelov S, Ruck C, Lindefors N, Kaldo V. Three-Year Follow-Up Comparing Cognitive Behavioral Therapy for Depression to Cognitive Behavioral Therapy for Insomnia, for Patients With Both Diagnoses. Sleep. 2017 Aug 1;40(8). doi: 10.1093/sleep/zsx108.

    PubMed 28655183
  • Blom K, Jernelov S, Ruck C, Lindefors N, Kaldo V. Three-Year Follow-Up of Insomnia and Hypnotics after Controlled Internet Treatment for Insomnia. Sleep. 2016 Jun 1;39(6):1267-74. doi: 10.5665/sleep.5850.

    PubMed 27091535
  • Blom K, Jernelov S, Kraepelien M, Bergdahl MO, Jungmarker K, Ankartjarn L, Lindefors N, Kaldo V. Internet treatment addressing either insomnia or depression, for patients with both diagnoses: a randomized trial. Sleep. 2015 Feb 1;38(2):267-77. doi: 10.5665/sleep.4412.

    PubMed 25337948

Questions about this trial

What is this clinical trial studying?

A study testing Therapist guided Internet-CBT for insomnia, Brief Internet-CBT for insomnia, without support and Therapist Guided Internet-CBT for depression in people with Insomnia and Depression, run by Karolinska Institutet at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Apr 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Insomnia Severity Index (ISI) (time frame: Post-treatment (9 weeks)). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01256099, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Apr 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in